» Articles » PMID: 38605663

Development and Feasibility Evaluation of Smart Cancer Care 2.0 Based on Patient-Reported Outcomes for Post-Discharge Management of Patients with Cancer

Overview
Specialty Oncology
Date 2024 Apr 12
PMID 38605663
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: A "Smart Cancer Care" platform that integrates patient-reported outcomes (PROs) with management has been established in Korea. This study focused on improving health behaviors and connecting patients to welfare services by introducing and assessing the feasibility of "Smart Cancer Care 2.0," an enhanced version designed for monitoring complications post-cancer treatment.

Materials And Methods: Smart Cancer Care 2.0 was developed by conducting a literature review and consulting with expert panels to identify symptoms or variables requiring monitoring and management guidelines based on the treatment type. Qualitative and quantitative surveys were conducted to assess the feasibility of the app and web system based on the experiences of patients with cancer and healthcare workers.

Results: A total of 81 symptoms or variables (chemotherapy-, surgery-, radiotherapy-, rehabilitation-, and health management-related) were selected for management in Smart Cancer Care 2.0. PROs for these symptoms were basically categorized into three severity grades: preventive management, self-treatment, and consultation with a healthcare worker or visit to a healthcare institution. The overall mean scores in the feasibility evaluation by patients and healthcare workers were 3.83 and 3.90 points, respectively, indicating high usefulness.

Conclusion: Smart Cancer Care 2.0 leverages the existing information and communication technologies-based platform, Smart Cancer Care, and further includes health behaviors and welfare services. Smart Cancer Care 2.0 may play a crucial role in establishing a comprehensive post-discharge management system for patients with cancer as it provides suitable interventions based on patients' responses and allows the regularly collected PROs to be easily viewed for streamlined care.

References
1.
Kang M, Won Y, Lee J, Jung K, Kim H, Kong H . Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019. Cancer Res Treat. 2022; 54(2):330-344. PMC: 9016309. DOI: 10.4143/crt.2022.128. View

2.
Pyo J, Ock M, Lee M, Kim J, Cheon J, Cho J . Unmet needs related to the quality of life of advanced cancer patients in Korea: a qualitative study. BMC Palliat Care. 2021; 20(1):58. PMC: 8045373. DOI: 10.1186/s12904-021-00749-8. View

3.
Glasgow T, McGuire K, Fuemmeler B . Eat, sleep, play: health behaviors and their association with psychological health among cancer survivors in a nationally representative sample. BMC Cancer. 2022; 22(1):648. PMC: 9190125. DOI: 10.1186/s12885-022-09718-7. View

4.
Lee H, Lim C, Yun H, Kang S, Kim D . Making an informed decision of Korean cancer patients: the discrepancy between a patient's recall of information and the information needed for acquisition of radiotherapy informed consent. Support Care Cancer. 2017; 26(1):297-303. DOI: 10.1007/s00520-017-3848-8. View

5.
Maguire R, McCann L, Kotronoulas G, Kearney N, Ream E, Armes J . Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART). BMJ. 2021; 374:n1647. PMC: 8293749. DOI: 10.1136/bmj.n1647. View